Everest Medicines Limited (6HN.F) Q3 2026 Earnings

17AugConfirmed
Q1 2025
Q3 2025
Q1 2026
Q3 2026
-0.16
-0.1
-0.05
0.01

Details

Expected EPS
-0.11816625942
Actual EPS
-0.00254120988
Surprise EPS
0.12
Surprise Percent
+97.85%

Description

Everest Medicines Limited (6HN.F) has reported earnings of -0.00254120988 per share for Q3 2026.

0 Comments

Share your thoughts